Categories Other Industries, U.S. Markets News
Not for sale, says Tesla rival on Ford takeover rumors
Ever since California-based Lucid Motors clinched a $1-billion investment from Saudi Arabia’s Public Investment Fund (PIF) beating bigger rival Tesla Inc (TSLA) in September last year, the electric vehicle maker has been in the limelight.
Now, the company is reportedly planning to share its electric vehicle technology with other automakers.
Lucid Motors CTO Peter Rawlinson told Bloomberg, “We’re actually currently in dialogue with companies that are interested in our technology. If there is an opportunity for partnership with some way that doesn’t dilute our brand and is beneficial, then that would be ultimately a board decision.”
Lucid Motors did not specify, which automakers they were in talks with.
Notably, Rawlinson is a former Tesla executive and has served as the chief engineer of Model S.
Rawlinson also rubbished rumors that the company was on sale, Ford (F) being the potential buyer. “We want to grow this business. Some sort of short-term move of a sale is just not on the agenda for me or any of the team. We see huge, long-term value for Lucid,” he told Bloomberg.
Read: Anti-climax: Tesla rival might bag Saudi investment
He added that Lucid Motors might go public once its Air is under production. The company will use the funding from the Saudi wealth fund to construct a manufacturing plant in Casa Grande, Arizona, where the production of Air would begin late next year.
The prototype of Lucid Air was unveiled in December 2016. The vehicle boasts of achieving acceleration of 0-60mph in just 2.5 seconds, with a top speed of 235mph. Market observers expect its price to be somewhere around $60,000.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference, and much more!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Comments